Oveporexton for treating type 1 narcolepsy [ID6622]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Tasimelteon for treating sleep disturbance associated with Smith-Magenis syndrome [TSID12191]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC